Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | ALKS |
---|---|---|
09:32 ET | 12554 | 24.76 |
09:34 ET | 400 | 24.58 |
09:36 ET | 500 | 24.72 |
09:38 ET | 1000 | 24.7 |
09:39 ET | 600 | 24.725 |
09:41 ET | 1113 | 24.81 |
09:43 ET | 400 | 24.81 |
09:45 ET | 600 | 24.82 |
09:48 ET | 3600 | 24.87 |
09:50 ET | 1300 | 24.87 |
09:52 ET | 2642 | 24.84 |
09:54 ET | 300 | 24.83 |
09:56 ET | 750 | 24.74 |
09:57 ET | 13168 | 24.91 |
09:59 ET | 800 | 24.94 |
10:01 ET | 900 | 25.03 |
10:06 ET | 261 | 25.035 |
10:08 ET | 3803 | 25.05 |
10:10 ET | 1356 | 24.99 |
10:12 ET | 300 | 24.985 |
10:14 ET | 200 | 24.99 |
10:15 ET | 566 | 24.97 |
10:17 ET | 4994 | 24.95 |
10:19 ET | 2632 | 24.98 |
10:21 ET | 2100 | 24.98 |
10:24 ET | 1000 | 25 |
10:26 ET | 1200 | 25.02 |
10:28 ET | 1755 | 25.04 |
10:30 ET | 3412 | 25.05 |
10:32 ET | 3393 | 25.07 |
10:33 ET | 1000 | 25.08 |
10:35 ET | 918 | 25.03 |
10:37 ET | 1115 | 25.04 |
10:39 ET | 1450 | 25.04 |
10:42 ET | 2412 | 25.03 |
10:44 ET | 2300 | 25.055 |
10:46 ET | 3600 | 25.06 |
10:48 ET | 1765 | 25.03 |
10:50 ET | 1806 | 24.98 |
10:51 ET | 1100 | 25 |
10:53 ET | 1600 | 24.985 |
10:55 ET | 299 | 24.97 |
10:57 ET | 1150 | 24.98 |
11:00 ET | 2791 | 25.01 |
11:02 ET | 1113 | 25.01 |
11:04 ET | 2800 | 25.04 |
11:06 ET | 1985 | 25.02 |
11:08 ET | 18529 | 25.035 |
11:09 ET | 3471 | 25.04 |
11:11 ET | 1778 | 25.08 |
11:13 ET | 1100 | 25.12 |
11:15 ET | 2249 | 25.13 |
11:18 ET | 1530 | 25.15 |
11:20 ET | 1300 | 25.145 |
11:22 ET | 5534 | 25.04 |
11:24 ET | 7373 | 25.03 |
11:26 ET | 1000 | 25.01 |
11:27 ET | 2282 | 25.01 |
11:29 ET | 2600 | 24.98 |
11:31 ET | 1575 | 24.98 |
11:33 ET | 8235 | 24.975 |
11:36 ET | 7179 | 24.95 |
11:38 ET | 9726 | 25.02 |
11:40 ET | 18811 | 24.99 |
11:42 ET | 11980 | 25.04 |
11:44 ET | 1792 | 24.99 |
11:45 ET | 2916 | 25.04 |
11:47 ET | 8541 | 25.07 |
11:49 ET | 700 | 25.055 |
11:51 ET | 2000 | 25.07 |
11:54 ET | 1300 | 25.07 |
11:56 ET | 1700 | 25.12 |
11:58 ET | 200 | 25.13 |
12:00 ET | 1495 | 25.13 |
12:02 ET | 2475 | 25.16 |
12:03 ET | 706 | 25.13 |
12:05 ET | 2738 | 25.16 |
12:07 ET | 1042 | 25.19 |
12:09 ET | 1841 | 25.18 |
12:12 ET | 774 | 25.21 |
12:14 ET | 500 | 25.2 |
12:16 ET | 1200 | 25.23 |
12:18 ET | 2500 | 25.225 |
12:20 ET | 8029 | 25.19 |
12:21 ET | 4981 | 25.14 |
12:23 ET | 2612 | 25.14 |
12:25 ET | 650 | 25.125 |
12:27 ET | 300 | 25.13 |
12:30 ET | 1150 | 25.16 |
12:32 ET | 1900 | 25.175 |
12:34 ET | 4743 | 25.22 |
12:36 ET | 2101 | 25.22 |
12:38 ET | 3826 | 25.26 |
12:39 ET | 1000 | 25.255 |
12:41 ET | 5337 | 25.19 |
12:43 ET | 1060 | 25.2 |
12:45 ET | 3910 | 25.19 |
12:48 ET | 1242 | 25.2 |
12:50 ET | 1400 | 25.185 |
12:52 ET | 3946 | 25.19 |
12:54 ET | 3007 | 25.17 |
12:56 ET | 5161 | 25.2 |
12:57 ET | 1200 | 25.22 |
12:59 ET | 1007 | 25.23 |
01:01 ET | 2842 | 25.2 |
01:03 ET | 1369 | 25.19 |
01:06 ET | 4664 | 25.22 |
01:08 ET | 2638 | 25.19 |
01:10 ET | 1117 | 25.18 |
01:12 ET | 4293 | 25.17 |
01:14 ET | 3265 | 25.19 |
01:15 ET | 1495 | 25.18 |
01:17 ET | 1236 | 25.185 |
01:19 ET | 3076 | 25.19 |
01:21 ET | 300 | 25.19 |
01:24 ET | 6072 | 25.22 |
01:26 ET | 2495 | 25.21 |
01:28 ET | 15242 | 25.12 |
01:30 ET | 9971 | 25.08 |
01:32 ET | 2766 | 25.07 |
01:33 ET | 2100 | 25.06 |
01:35 ET | 3128 | 25.105 |
01:37 ET | 1464 | 25.11 |
01:39 ET | 2360 | 25.09 |
01:42 ET | 3707 | 25.07 |
01:44 ET | 5856 | 25.05 |
01:46 ET | 3817 | 25.1 |
01:48 ET | 2170 | 25.11 |
01:50 ET | 1400 | 25.11 |
01:51 ET | 3591 | 25.09 |
01:53 ET | 1015 | 25.09 |
01:55 ET | 2872 | 25.07 |
01:57 ET | 3363 | 25.07 |
02:00 ET | 1496 | 25.09 |
02:02 ET | 1500 | 25.06 |
02:04 ET | 1112 | 25.075 |
02:06 ET | 5118 | 25.05 |
02:08 ET | 4151 | 25.1 |
02:09 ET | 1000 | 25.12 |
02:11 ET | 600 | 25.1 |
02:13 ET | 2676 | 25.085 |
02:15 ET | 1805 | 25.08 |
02:18 ET | 3693 | 25.07 |
02:20 ET | 3362 | 25.03 |
02:22 ET | 3882 | 25.065 |
02:24 ET | 1250 | 25.08 |
02:26 ET | 5785 | 25.03 |
02:27 ET | 16888 | 24.99 |
02:29 ET | 6894 | 25 |
02:31 ET | 2400 | 25 |
02:33 ET | 4036 | 24.96 |
02:36 ET | 3570 | 24.985 |
02:38 ET | 3700 | 24.97 |
02:40 ET | 1200 | 24.96 |
02:42 ET | 18100 | 24.96 |
02:44 ET | 32497 | 24.91 |
02:45 ET | 5432 | 24.915 |
02:47 ET | 2394 | 24.931 |
02:49 ET | 28730 | 24.95 |
02:51 ET | 1157 | 24.94 |
02:54 ET | 5344 | 25.005 |
02:56 ET | 6945 | 24.985 |
02:58 ET | 2846 | 24.96 |
03:00 ET | 8263 | 24.95 |
03:02 ET | 3698 | 24.88 |
03:03 ET | 5272 | 24.83 |
03:05 ET | 1100 | 24.87 |
03:07 ET | 6090 | 24.8 |
03:09 ET | 6190 | 24.8 |
03:12 ET | 7426 | 24.8 |
03:14 ET | 500 | 24.8 |
03:16 ET | 3000 | 24.79 |
03:18 ET | 33070 | 24.775 |
03:20 ET | 8998 | 24.77 |
03:21 ET | 12084 | 24.785 |
03:23 ET | 25363 | 24.8 |
03:25 ET | 22404 | 24.77 |
03:27 ET | 2171 | 24.785 |
03:30 ET | 13397 | 24.74 |
03:32 ET | 5481 | 24.75 |
03:34 ET | 54183 | 24.75 |
03:36 ET | 6342 | 24.73 |
03:38 ET | 15523 | 24.755 |
03:39 ET | 6153 | 24.74 |
03:41 ET | 2380 | 24.74 |
03:43 ET | 5977 | 24.72 |
03:45 ET | 53325 | 24.69 |
03:48 ET | 16874 | 24.675 |
03:50 ET | 12934 | 24.665 |
03:52 ET | 34274 | 24.6475 |
03:54 ET | 54492 | 24.715 |
03:56 ET | 33571 | 24.825 |
03:57 ET | 32825 | 24.82 |
03:59 ET | 311952 | 24.88 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
Alkermes Plc | 4.2B | 8.2x | --- |
Exelixis Inc | 7.0B | 36.7x | -21.77% |
Sinovac Biotech Ltd | 639.9M | -1.8x | +15.89% |
Halozyme Therapeutics Inc | 4.9B | 18.4x | --- |
PTC Therapeutics Inc | 2.2B | -4.2x | --- |
P3 Health Partners Inc | 141.0M | -0.7x | --- |
Alkermes plc is a global biopharmaceutical company that seeks to develop medicines in the field of neuroscience. The Company has a portfolio of commercial products for the treatment of alcohol dependence, opioid dependence, schizophrenia and bipolar I disorder and a pipeline of clinical and preclinical candidates in development for neurological disorders. It focuses on commercial products, such as LYBALVI, ARISTADA/ARISTADA INITIO and VIVITROL, and advancing the development of pipeline programs focused on neurological disorders. LYBALVI is a once-daily, oral atypical antipsychotic drug for the treatment of adults with schizophrenia and for the treatment of adults with bipolar I disorder, as a maintenance monotherapy or for the acute treatment of manic or mixed episodes, as monotherapy or an adjunct to lithium or valproate. ARISTADA is an extended-release intramuscular injectable suspension for the treatment of schizophrenia. It has a manufacturing facility in Wilmington, Ohio.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $4.2B |
---|---|
Revenue (TTM) | $1.7B |
Shares Outstanding | 169.2M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 0.57 |
EPS | $3.02 |
Book Value | $7.20 |
P/E Ratio | 8.2x |
Price/Sales (TTM) | 2.5 |
Price/Cash Flow (TTM) | 7.0x |
Operating Margin | 24.90% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.